Cargando…

Clinicopathological Significance of Expression of CD44 Variants in Head and Neck Squamous Cell Carcinoma

Splice variants of the cell surface glycoprotein CD44 have been reported to be associated with the progression of various human tumors. The aim of this study is to determine the correlation between the expression of CD44 isoforms, especially CD44 variant 2 (CD44v2), and the clinicopathological featu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanke, Minoru, Fujii, Masato, Kameyama, Kaori, Kanzaki, Jin, Tokumaru, Yutaka, Imanishi, Yorihisa, Tomita, Toshiki, Matsumura, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2000
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926470/ https://www.ncbi.nlm.nih.gov/pubmed/10804289 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00960.x

Ejemplares similares

Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
por: Habu, Noboru, et al.
Publicado: (2015)

Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma
por: Fujii, Ryoichi, et al.
Publicado: (2014)

Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer
por: Baba, Yuh, et al.
Publicado: (2012)

Characterization of CD44 variant expression in head and neck squamous cell carcinomas
por: Spiegelberg, D., et al.
Publicado: (2013)

Expression of CD44 in Head and Neck Squamous Cell Carcinoma—An In-Silico Study
por: Kavitha, Loganathan, et al.
Publicado: (2023)

Clinicopathological Parameters Predicting Nodal Metastasis in Head and Neck Squamous Cell Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2023)

Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.
por: Janot, F., et al.
Publicado: (1996)

Necroptosis in head and neck squamous cell carcinoma: characterization of clinicopathological relevance and in vitro cell model
por: Li, Jingyuan, et al.
Publicado: (2020)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma
por: Odenthal, Julia, et al.
Publicado: (2018)

Tumours of the head and neck in children—clinicopathologic perspectives
por: Mott, M.G.
Publicado: (1983)

Clinicopathological study of patients with head and neck sarcomas
por: Pacheco, Isabela Alves, et al.
Publicado: (2015)

Pain in the neck: Bench press injury
por: Chiba, Takuyo, et al.
Publicado: (2023)

The Clinicopathological Significance of Epithelial Mesenchymal Transition Associated Protein Expression in Head and Neck Squamous Cell Carcinoma
por: Kim, Kyu Ho, et al.
Publicado: (2014)

Clinicopathological Significance of FOXO4 Expression and Correlation with Prx1 in Head and Neck Squamous Cell Carcinoma
por: Lu, Yunping, et al.
Publicado: (2021)

Assessment of immunohistochemical expression of p16 in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters
por: Pandey, Pinki, et al.
Publicado: (2021)

Clinicopathological Parameters and Biomarker Profile in a Cohort of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Hashmi, Atif A, et al.
Publicado: (2023)

CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches
por: Spiegelberg, Diana, et al.
Publicado: (2017)

Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells
por: Hamada, Masakazu, et al.
Publicado: (2017)

Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma
por: Yan, Shufang, et al.
Publicado: (2022)

Clinicopathology and Treatment Patterns of Head and Neck Cancers in Ethiopia
por: Fekadu, Adugna, et al.
Publicado: (2022)

Randomized Phase III Trial of Adjuvant Chemotherapy with S-1 after Curative Treatment in Patients with Squamous-Cell Carcinoma of the Head and Neck (ACTS-HNC)
por: Tsukahara, Kiyoaki, et al.
Publicado: (2015)

Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study
por: Kubota, Akira, et al.
Publicado: (2018)

Comprehensive Analysis of DNA Methylation in Head and Neck Squamous Cell Carcinoma Indicates Differences by Survival and Clinicopathologic Characteristics
por: Colacino, Justin A., et al.
Publicado: (2013)

Prognostic and clinicopathological significance of tumor-stroma ratio in head and neck squamous cell carcinoma: A systematic review
por: de Morais, Everton Freitas, et al.
Publicado: (2022)

PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma
por: Lee, Yunqin, et al.
Publicado: (2014)

CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma
por: Ciulean, Ioana Sonya, et al.
Publicado: (2023)

Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma
por: Mikoshiba, Takuya, et al.
Publicado: (2020)

Cyclooxygenase-2 expression is associated with chemoresistance through cancer stemness property in hypopharyngeal carcinoma
por: Saito, Shin, et al.
Publicado: (2021)

Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma
por: Shimanuki, Marie, et al.
Publicado: (2018)

Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma
por: Ohmoto, Akihiro, et al.
Publicado: (2021)

Teratocarcinosarcoma of the head and neck: Clinicopathologic review of a rare entity
por: AL-Zaidi, Rana S.
Publicado: (2023)

Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: González-Moles, Miguel Ángel, et al.
Publicado: (2020)

An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma
por: Cui, Jie, et al.
Publicado: (2019)

Clinicopathological characteristics and clinical morbidity in high‐risk head and neck cutaneous squamous cell carcinoma patients in Western Australia
por: Grover, Piyush, et al.
Publicado: (2022)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field
por: Su, Zhan, et al.
Publicado: (2019)

CD44 Variant Isoform Expression and Breast Cancer Prognosis
por: Tokue, Yutaka, et al.
Publicado: (1998)

Clinical outcomes of transoral videolaryngoscopic surgery for hypopharyngeal and supraglottic cancer
por: Imanishi, Yorihisa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_56hllrasq79jh7rdfgsa8d1f42